Clinical Trial Update: Post Market Observational Retrospective Study of Glycar Bovine Pericardial Patch (CIP-003)

View source ↗

Summary

A post-market observational retrospective study of the Glycar Bovine Pericardial Patch (CIP-003) has completed to assess outcomes in patients with cardiac and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Anomaly
• Cardiac Defect
• Pericardial Defect

Snippet

Sponsor: GLYCAR SA (Pty) Ltd | Conditions: Cardiac Defect, Cardiac Anomaly | Status: COMPLETED